Mortek Danmark ApS
CVRCVR number42791237
Company financials
Key figures
Updated 21 Jun 2026
- Return on assets
- –
- Return on equity
- -23.3%
- Current ratio
- 223.9%
- Equity ratio
- 55.3%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -157,932 |
Finance income | 28,686 |
Finance expenses | 39,200 |
Tax expense | -36,932 |
Profit/loss for the year | -131,514 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 1 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 7,303 |
Current assets | 1,018,356 |
Total assets | 1,018,356 |
Equity | 563,598 |
Liabilities | 454,758 |
Current liabilities | 454,758 |
Working capital
| Reporting period | |
|---|---|
Inventories | 275,694 |
Trade receivables | 597,634 |
Trade payables | 4,167 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 40,000 |
Retained earnings | 523,598 |
Proposed dividend recognised in equity | 0 |
Annual report highlights
Official annual report · 2025
Business and development
Primary activities
Selskabets væsentligste aktivitet er at købe og sælge medicinsk udstyr.
Development in activities and financial affairs
Selskabets resultatopgørelse for 2025 udviser et underskud på kr. 131.514, og selskabets balance pr. 31. december 2025 udviser en egenkapital på kr. 563.598.
Risks and material matters
Significant events after the reporting period
Der er efter regnskabsårets afslutning ikke indtruffet begivenheder, som væsentligt vil kunne påvirke selskabets finansielle stilling.
Commitments and security
Mortgages and collateral
Selskabet har ingen pantsætninger og sikkerhedsstillelser pr. 31. december 2025
Create a free account to see up to 9 years of financial history
Create free account